• FAISL Stabilizes FAK Through Calpain-2 in TNBC

  2026-08-13

  The reference study identifies FAISL as a long noncoding RNA that preserves focal adhesion kinase by preventing calpain-2-mediated proteolysis. Its findings connect lncRNA-dependent control of FAK protein stability with triple-negative breast cancer adhesion, growth, and metastasis, while also illustrating why protease regulation should be evaluated alongside kinase signaling.

• Recombinant Human IL-15: Assays and Applications

  2026-08-13

  Build reproducible T-cell, NK-cell, and cytokine-response assays with a tag-free, high-purity Interleukin-15 reagent. This workflow also shows how immune-cell measurements can complement, but not replace, circuit-level studies of early life adversity and innate defensive behavior.

• NLRP3 Astrocyte Remodeling in Morphine Tolerance

  2026-08-12

  Yuan et al. identify NLRP3 inflammasome activation as a mechanistic link between repeated morphine exposure and a shift toward an A1-like reactive astrocyte profile. The study combines behavioral, molecular, and spatial measurements to show that MCC950 slows tolerance development while normalizing inflammatory and astrocyte phenotype markers.

• Pam3CSK4 TFA in Translational TLR1/2 Research

  2026-08-12

  A mechanistic and strategic guide to using Pam3CSK4 TFA as a standardized TLR1/2 agonist for innate immune profiling, inflammatory modeling, and translational maternal-neonatal research.

• PEDV Replication Depends on IMPDH-Driven Nucleotide Supply

  2026-08-11

  The reference study combines untargeted metabolomics with IMPDH2 knockdown and merimepodib treatment to show that porcine epidemic diarrhea virus (PEDV) depends on host guanine nucleotide biosynthesis. Its cell-type comparison and orthogonal validation identify IMPDH as a host-directed antiviral target while clarifying the metabolic basis of PEDV replication.

• Recombinant Human IL-15 in Neuroimmune Research

  2026-08-11

  Early life adversity research identifies oxytocin signaling in the superior colliculus as a regulator of innate defensive behavior. This thought-leadership perspective explains how Recombinant Human IL-15 can support carefully bounded immune-cell experiments that test, rather than assume, neuroimmune links.

• Extrahepatic mRNA Delivery with Virus-Mimicking Particles

  2026-08-10

  The reference study introduces a self-assembling enveloped virus-mimicking particle that combines engineered RNA-binding peptides with programmable phospholipid envelopes to overcome the hepatic bias of many mRNA delivery systems. Its lung and spleen targeting results, together with IL-12 mRNA activity in a metastatic lung tumor model, provide a useful framework for evaluating extrahepatic cytokine delivery while highlighting the need for further translational validation.

• PBA-Modified PAD4 Inhibitors Suppress Tumor NETs

  2026-08-09

  The reference study developed phenylboronic acid-modified PAD4 inhibitors, identifying Compound 5i as a tumor-targeted agent that suppresses the PAD4–H3cit–NET axis. Across sarcoma and breast cancer models, the compound reduced tumor growth and metastasis while producing a favorable safety and immune-microenvironment profile.

• CLCC1 and Herpesvirus Nuclear Egress Fusion

  2026-08-08

  A 2024 bioRxiv preprint identifies the host protein CLCC1 as essential for membrane fusion during herpes simplex virus 1 nuclear egress, distinguishing this step from viral NEC-driven budding. The findings connect herpesvirus capsid export with nuclear pore membrane insertion and provide a mechanistic basis for studying host-dependent stages of viral replication.

• MCC950 sodium in Reliable Cell Assays

  2026-08-07

  Learn how MCC950 sodium, SKU B7946, can help separate NLRP3-driven inflammatory cell death from nonspecific assay variability. This scenario-based guide covers assay design, dose selection, interpretation, and practical product-selection criteria for biomedical laboratories.

• NBC19: Applied NLRP3 Inflammasome Inhibitor Workflows & Insi

  2026-08-07

  NBC19 delivers nanomolar precision for dissecting NLRP3 inflammasome activation, enabling robust IL-1β release inhibition under diverse inflammatory stimuli. This guide bridges advanced experimental protocols with troubleshooting strategies, translating recent discoveries on macrophage-driven inflammation and metastatic microenvironments into actionable laboratory workflows.

• Maternal IL-17A Predicts Neonatal Risk in GBS Colonization

  2026-08-06

  This study identifies maternal IL-17A as a robust prognostic biomarker for neonatal invasive disease in pregnancies complicated by Group B Streptococcus (GBS) colonization. By integrating cytokine profiling and ex vivo TLR1/2 pathway activation, the work advances risk stratification in perinatal infection and informs immunological research protocols.

• Discovery and Characterization of MK 0893 as a Glucagon Rece

  2026-08-06

  The reference study details the optimization and preclinical evaluation of MK 0893, a potent, selective, and orally active glucagon receptor antagonist. Its high affinity and efficacy in reducing glucose excursions in diabetic models highlight its value for advancing type 2 diabetes research.

• Pam3CSK4 TFA (SKU B5662): Robust TLR1/2 Agonist for Immunity

  2026-08-05

  This article addresses real-world challenges in cell-based immunology assays, demonstrating how Pam3CSK4 TFA (SKU B5662) enables reproducible, high-fidelity TLR1/2 activation. With scenario-driven analysis, it guides biomedical researchers through protocol optimization, data interpretation, and reliable vendor selection, all grounded in validated best practices and robust supplier quality.

• Pomalidomide (CC-4047) for Reliable Myeloma Research Workflo

  2026-08-05

  This article delivers scenario-driven guidance for using Pomalidomide (CC-4047) (SKU A4212) to overcome common experimental pitfalls in hematological malignancy research. Drawing on published data and validated protocols, it addresses assay reproducibility, cytokine modulation, and vendor selection, positioning SKU A4212 as a robust solution for cell-based studies.

16393 records 1/1093 page Next 12345 下5页 Last page